Menu
Pipeline
Through joint collaborations with top pharmaceutical companies and research institutions, KREX has been used to identify autoantibody biomarkers for commercial diagnostics and screening applications. In addition, KREX has also been used to identify biologics with therapeutics potential.
Project
Pilot
Candidate id
Validation
Clinical Trial
Commercialisation
Companion Diagnostics
Cancer Immunotherapy PD1 inhibitor
Autoimmune Disease Drug 1
Autoimmune Disease Drug 2
Disease Diagnostics
Melanoma
NSCLC
Gastric Cancer
Breast Cancer
Therapeutic Autoantibodies
Rheumatoid Arthritis – A
Autism
Lupus
Parkinson’s
Aging
Rheumatoid Arthritis – B
FEATURED PRODUCTS
IMMUNOME
Protein Array
High-throughput
sero-profiling platform
CTA
Protein Array
Screening of
cancer-testis antigens
OncoREX p53
Cancer Array
Cancer drug
screening and discovery
Custom
Protein Array
Flexible format for
high-throughput screening
2008 – 2019 © Sengenics All rights reserved | Sengenics Corporation Pte Ltd. Registered in Singapore no. 201734100D | Sengenics UK Ltd. Registered in England and Wales No 11016361
